T1	PROC 46 56	Prevención
#1	AnnotatorNotes T1	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T2	DISO 63 96	infección por el virus SARS-CoV-2
T3	DISO 118 137	enfermedad CoVid-19
#2	AnnotatorNotes T3	C5203670; COVID19 (disease); Disease or Syndrome
T4	CHEM 162 179	hidroxicloroquina
#3	AnnotatorNotes T4	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T5	CHEM 217 234	hidroxicloroquina
#4	AnnotatorNotes T5	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T6	PROC 241 251	prevención
#5	AnnotatorNotes T6	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T7	DISO 258 282	infección por SARS-CoV-2
#6	AnnotatorNotes T7	C5203670; COVID19 (disease); Disease or Syndrome
T8	DISO 304 323	enfermedad CoVid-19
#7	AnnotatorNotes T8	C5203670; COVID19 (disease); Disease or Syndrome
T9	DISO 368 392	Infección por SARS-SoV-2
T10	DISO 395 414	enfermedad CoVid-19
#8	AnnotatorNotes T10	C5203670; COVID19 (disease); Disease or Syndrome
T11	DISO 455 479	Infección por SARS-SoV-2
T12	DISO 482 501	enfermedad CoVid-19
#9	AnnotatorNotes T12	C5203670; COVID19 (disease); Disease or Syndrome
T13	PROC 608 638	seguimiento rutinario prenatal
#10	AnnotatorNotes T13	C0262603; PRENATAL MATERNAL FOLLOWUP ASSESSMENT; Diagnostic Procedure
T14	DISO 680 688	síntomas
#11	AnnotatorNotes T14	C1457887; Symptoms; Sign or Symptom
T15	DISO 689 695	signos
#12	AnnotatorNotes T15	C0311392; Physical findings; Finding
T16	DISO 710 734	infección por SARS-CoV-2
#13	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	DISO 792 816	infección por SARS-CoV-2
#14	AnnotatorNotes T17	C5203670; COVID19 (disease); Disease or Syndrome
T18	PROC 823 841	electrocardiograma
#15	AnnotatorNotes T18	C0013798; Electrocardiogram; Diagnostic Procedure | C1623258; Electrocardiography; Diagnostic Procedure
T19	DISO 866 875	arritmias
#16	AnnotatorNotes T19	C0003811; Cardiac Arrhythmia; Disease or Syndrome
T20	PROC 1022 1052	seguimiento rutinario prenatal
#17	AnnotatorNotes T20	C0262603; PRENATAL MATERNAL FOLLOWUP ASSESSMENT; Diagnostic Procedure
T21	PROC 1091 1102	diagnóstico
#18	AnnotatorNotes T21	C0011900; Diagnosis; Diagnostic Procedure
T22	DISO 1125 1149	infección por SARS-CoV-2
#19	AnnotatorNotes T22	C5203670; COVID19 (disease); Disease or Syndrome
T23	DISO 1164 1170	signos
#20	AnnotatorNotes T23	C0311392; Physical findings; Finding
T24	DISO 1155 1163	síntomas
#21	AnnotatorNotes T24	C1457887; Symptoms; Sign or Symptom
T25	DISO 1183 1191	síntomas
#22	AnnotatorNotes T25	C1457887; Symptoms; Sign or Symptom
T26	DISO 1192 1198	signos
#23	AnnotatorNotes T26	C0311392; Physical findings; Finding
T27	DISO 1213 1222	infección
#24	AnnotatorNotes T27	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T28	PROC 1306 1336	seguimiento rutinario prenatal
#25	AnnotatorNotes T28	C0262603; PRENATAL MATERNAL FOLLOWUP ASSESSMENT; Diagnostic Procedure
T29	DISO 1494 1503	infección
#26	AnnotatorNotes T29	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T30	CHEM 1574 1577	HCQ
T31	DISO 1551 1568	hipersensibilidad
#27	AnnotatorNotes T31	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T32	DISO 1629 1640	retinopatía
#28	AnnotatorNotes T32	C0035309; Retinal Diseases; Disease or Syndrome
T33	CHEM 1685 1693	digoxina
#29	AnnotatorNotes T33	C0012265; digoxin; Organic Chemical · Pharmacologic Substance
T34	CHEM 1695 1707	ciclosporina
#30	AnnotatorNotes T34	C0010592; cyclosporine; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T35	CHEM 1709 1719	cimetidina
#31	AnnotatorNotes T35	C0008783; cimetidine; Organic Chemical · Pharmacologic Substance
T36	DISO 1733 1752	enfermedad hepática
#32	AnnotatorNotes T36	C0023895; Liver diseases; Disease or Syndrome
T37	ANAT 1794 1802	cardíaca
#33	AnnotatorNotes T37	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T38	ANAT 1839 1847	cardiaca
#34	AnnotatorNotes T38	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T39	PROC 1854 1872	electrocardiograma
#35	AnnotatorNotes T39	C0013798; Electrocardiogram; Diagnostic Procedure | C1623258; Electrocardiography; Diagnostic Procedure
T40	CHEM 1588 1615	compuestos 4-amonoquinolina
T41	CHEM 1722 1731	tamoxifen
T42	PROC 761 764	PCR
#36	AnnotatorNotes T42	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T43	PROC 1118 1121	PCR
#37	AnnotatorNotes T43	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T44	PROC 1376 1379	PCR
#38	AnnotatorNotes T44	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T45	ANAT 1744 1752	hepática
#39	AnnotatorNotes T45	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T46	DISO 1783 1802	enfermedad cardíaca
T47	DISO 1829 1847	patología cardiaca
T48	Date 13 17	2020
T49	LIVB 80 96	virus SARS-CoV-2
#40	AnnotatorNotes T49	C5203676; SARS-CoV-2; Virus
T50	PHYS 149 157	embarazo
#41	AnnotatorNotes T50	C0032961; Pregnancy; Organism Function
T51	PHYS 335 343	embarazo
#42	AnnotatorNotes T51	C0032961; Pregnancy; Organism Function
T52	LIVB 416 427	coronavirus
#43	AnnotatorNotes T52	C5203676; SARS-CoV-2; Virus
T53	LIVB 528 547	Mujeres embarazadas
#44	AnnotatorNotes T53	C0033011; Pregnant Women; Population Group
T54	Date 630 638	prenatal
#45	AnnotatorNotes T54	C2828394; Prenatal (temporal qualifier); Temporal Concept
T55	Neg_cue 676 679	sin
T56	Spec_cue 696 709	sugestivos de
T57	Spec_cue 770 791	confirmar o descartar
T58	Spec_cue 857 865	posibles
T60	LIVB 881 888	mujeres
#46	AnnotatorNotes T60	C0043210; Woman; Population Group
T61	LIVB 942 961	Mujeres embarazadas
#47	AnnotatorNotes T61	C0033011; Pregnant Women; Population Group
T62	Date 1044 1052	prenatal
#48	AnnotatorNotes T62	C2828394; Prenatal (temporal qualifier); Temporal Concept
T63	Neg_cue 1179 1182	sin
T64	Spec_cue 1199 1212	sugestivos de
T65	LIVB 1226 1245	Mujeres embarazadas
#49	AnnotatorNotes T65	C0033011; Pregnant Women; Population Group
T66	Date 1328 1336	prenatal
#50	AnnotatorNotes T66	C2828394; Prenatal (temporal qualifier); Temporal Concept
T67	Neg_cue 1380 1391	negativa de
T68	LIVB 1392 1402	SARS-CoV-2
#51	AnnotatorNotes T68	C5203676; SARS-CoV-2; Virus
T69	Spec_cue 1480 1493	sospechoso de
T70	Spec_cue 1815 1828	sugestivos de
T71	LIVB 1891 1898	mujeres
#52	AnnotatorNotes T71	C0043210; Woman; Population Group
T72	Neg_cue 1977 1986	excluidas
T73	PHYS 536 547	embarazadas
#53	AnnotatorNotes T73	C0032961; Pregnancy; Organism Function
T59	PHYS 950 961	embarazadas
#54	AnnotatorNotes T59	C0032961; Pregnancy; Organism Function
T74	PHYS 1234 1245	embarazadas
#55	AnnotatorNotes T74	C0032961; Pregnancy; Organism Function
T75	LIVB 272 282	SARS-CoV-2
#56	AnnotatorNotes T75	C5203676; SARS-CoV-2; Virus
T76	LIVB 382 392	SARS-SoV-2
#57	AnnotatorNotes T76	C5203676; SARS-CoV-2; Virus
T77	LIVB 469 479	SARS-SoV-2
#58	AnnotatorNotes T77	C5203676; SARS-CoV-2; Virus
T78	LIVB 724 734	SARS-CoV-2
#59	AnnotatorNotes T78	C5203676; SARS-CoV-2; Virus
T79	LIVB 806 816	SARS-CoV-2
#60	AnnotatorNotes T79	C5203676; SARS-CoV-2; Virus
T80	LIVB 1139 1149	SARS-CoV-2
#61	AnnotatorNotes T80	C5203676; SARS-CoV-2; Virus
T81	PROC 561 577	edad gestational
#62	AnnotatorNotes T81	C4040272; Assessment of fetal gestational age; Health Care Activity
T82	PHYS 566 577	gestational
#63	AnnotatorNotes T82	C0032961; Pregnancy; Organism Function
T83	PHYS 980 991	gestacional
#64	AnnotatorNotes T83	C0032961; Pregnancy; Organism Function
T84	PROC 975 991	edad gestacional
#65	AnnotatorNotes T84	C4040272; Assessment of fetal gestational age; Health Care Activity
T85	PROC 1259 1275	edad gestacional
#66	AnnotatorNotes T85	C4040272; Assessment of fetal gestational age; Health Care Activity
T86	PHYS 1264 1275	gestacional
#67	AnnotatorNotes T86	C0032961; Pregnancy; Organism Function
T87	Observation 1921 1965	llevar a cabo los requerimientos del estudio
#68	AnnotatorNotes T87	C1302261; Patient eligible for clinical trial; Finding (?)
T88	Observation 1413 1464	contactos (a nivel del hogar) de un caso confirmado
#69	AnnotatorNotes T88	C5419476; Household Contact with SARS-CoV-2 Positive Individual; Finding
A1	Assertion T14 Negated
A2	Assertion T15 Negated
A3	Assertion T16 Speculated
A4	Assertion T17 Speculated
A5	Assertion T19 Speculated
A6	Assertion T25 Negated
A7	Assertion T26 Negated
A8	Assertion T27 Speculated
A9	Assertion T68 Negated
A10	Assertion T29 Speculated
A11	Assertion T47 Speculated
A12	Assertion T71 Negated
A13	Status T31 History_of
A14	Status T32 History_of
A15	Status T46 History_of
A16	Status T36 History_of
A17	Assertion T87 Negated
#70	AnnotatorNotes T30	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance 
#71	AnnotatorNotes T47	C0018799; Heart Diseases; Disease or Syndrome
#72	AnnotatorNotes T46	C0018799; Heart Diseases; Disease or Syndrome
R1	Causes Arg1:T49 Arg2:T2	
#73	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
#74	AnnotatorNotes T9	C5203670; COVID19 (disease); Disease or Syndrome
#75	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
R2	Location_of Arg1:T45 Arg2:T36	
R3	Negation Arg1:T72 Arg2:T71	
T89	Neg_cue 1908 1920	incapaces de
R5	Negation Arg1:T89 Arg2:T87	
R6	Before Arg1:T1 Arg2:T2	
R7	Before Arg1:T1 Arg2:T3	
R8	Overlap Arg1:T3 Arg2:T50	
R9	Used_for Arg1:T4 Arg2:T1	
R10	Overlap Arg1:T2 Arg2:T50	
R11	Causes Arg1:T49 Arg2:T3	
R12	Used_for Arg1:T5 Arg2:T6	
R13	Before Arg1:T6 Arg2:T7	
R14	Causes Arg1:T75 Arg2:T7	
R15	Causes Arg1:T75 Arg2:T8	
R16	Overlap Arg1:T8 Arg2:T51	
R17	Overlap Arg1:T7 Arg2:T51	
R18	Overlap Arg1:T1 Arg2:T50	
R19	Overlap Arg1:T6 Arg2:T51	
R20	Causes Arg1:T76 Arg2:T10	
R21	Causes Arg1:T76 Arg2:T9	
R22	Causes Arg1:T77 Arg2:T11	
R23	Causes Arg1:T77 Arg2:T12	
R24	Causes Arg1:T52 Arg2:T10	
R25	Causes Arg1:T52 Arg2:T9	
R26	Experiences Arg1:T53 Arg2:T73	
R27	Overlap Arg1:T13 Arg2:T54	
R28	Experiences Arg1:T53 Arg2:T81	
R29	Negation Arg1:T55 Arg2:T14	
R30	Negation Arg1:T55 Arg2:T15	
R31	Speculation Arg1:T56 Arg2:T16	
R32	Experiences Arg1:T53 Arg2:T14	
R33	Experiences Arg1:T53 Arg2:T15	
R34	Experiences Arg1:T53 Arg2:T16	
R35	Causes Arg1:T78 Arg2:T16	
R36	Causes Arg1:T16 Arg2:T14	
R37	Causes Arg1:T16 Arg2:T15	
R41	Speculation Arg1:T57 Arg2:T17	
R42	Causes Arg1:T79 Arg2:T17	
R43	Speculation Arg1:T58 Arg2:T19	
R44	Experiences Arg1:T60 Arg2:T19	
R45	Experiences Arg1:T60 Arg2:T42	
R46	Experiences Arg1:T60 Arg2:T18	
R47	Experiences Arg1:T60 Arg2:T17	
R48	Experiences Arg1:T61 Arg2:T59	
R49	Experiences Arg1:T61 Arg2:T84	
R50	Overlap Arg1:T20 Arg2:T62	
R51	Experiences Arg1:T61 Arg2:T43	
R52	Causes Arg1:T80 Arg2:T22	
R53	Experiences Arg1:T61 Arg2:T22	
R54	Causes Arg1:T22 Arg2:T24	
R55	Causes Arg1:T22 Arg2:T23	
T90	Quantifier_or_Qualifier 1171 1176	leves
#76	AnnotatorNotes T90	C2945599; Mild (qualifier value); Qualitative Concept
R56	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T90	
R57	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T90	
R58	Negation Arg1:T63 Arg2:T25	
R59	Negation Arg1:T63 Arg2:T26	
R60	Experiences Arg1:T61 Arg2:T25	
R61	Experiences Arg1:T61 Arg2:T26	
R62	Speculation Arg1:T64 Arg2:T27	
R63	Causes Arg1:T27 Arg2:T26	
R64	Causes Arg1:T27 Arg2:T25	
R65	Experiences Arg1:T61 Arg2:T27	
R66	Experiences Arg1:T61 Arg2:T24	
R67	Experiences Arg1:T61 Arg2:T23	
R68	Experiences Arg1:T61 Arg2:T83	
R69	Experiences Arg1:T53 Arg2:T82	
R70	Experiences Arg1:T65 Arg2:T74	
R71	Experiences Arg1:T65 Arg2:T85	
R72	Experiences Arg1:T65 Arg2:T86	
R73	Overlap Arg1:T28 Arg2:T66	
R80	Negation Arg1:T67 Arg2:T68	
T91	Observation 1380 1402	negativa de SARS-CoV-2
R81	Has_Result_or_Value Arg1:T44 Arg2:T91	
R82	Experiences Arg1:T65 Arg2:T88	
R83	Speculation Arg1:T69 Arg2:T29	
R84	Experiences Arg1:T65 Arg2:T29	
R85	Before Arg1:T43 Arg2:T21	
R87	Causes Arg1:T30 Arg2:T31	
R88	Causes Arg1:T40 Arg2:T31	
T92	Quantifier_or_Qualifier 1669 1681	concomitante
#77	AnnotatorNotes T92	C0521115; Simultaneous; Temporal Concept
R89	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T92	
R90	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T92	
R91	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T92	
R92	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T92	
R93	Location_of Arg1:T37 Arg2:T46	
R94	Speculation Arg1:T70 Arg2:T47	
R95	Location_of Arg1:T38 Arg2:T47	
R96	Experiences Arg1:T65 Arg2:T91	
R98	Before Arg1:T4 Arg2:T3	
R99	Before Arg1:T4 Arg2:T2	
R100	Before Arg1:T5 Arg2:T7	
R101	Before Arg1:T5 Arg2:T8	
T93	Observation 1413 1422;1443 1453;1467 1503	contactos de un caso clínicamente sospechoso de infección
T94	Quantifier_or_Qualifier 102 111	severidad
R102	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T94	
T95	Quantifier_or_Qualifier 288 297	severidad
R103	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T95	
#78	AnnotatorNotes T94	C1547227; Severe - Severity of Illness Code; Intellectual Product (?)
#79	AnnotatorNotes T95	C1547227; Severe - Severity of Illness Code; Intellectual Product (?)
#80	AnnotatorNotes T40	C0048060; 4-aminoquinoline; Organic Chemical · Pharmacologic Substance (?)
#81	AnnotatorNotes T41	C0039286; tamoxifen; Organic Chemical · Pharmacologic Substance
R38	Overlap Arg1:T73 Arg2:T14	
R39	Overlap Arg1:T73 Arg2:T15	
R40	Overlap Arg1:T73 Arg2:T16	
R104	Overlap Arg1:T82 Arg2:T14	
R105	Overlap Arg1:T82 Arg2:T15	
R106	Overlap Arg1:T82 Arg2:T16	
R74	Overlap Arg1:T59 Arg2:T22	
R75	Overlap Arg1:T59 Arg2:T24	
R76	Overlap Arg1:T59 Arg2:T23	
R77	Overlap Arg1:T83 Arg2:T22	
R78	Overlap Arg1:T83 Arg2:T24	
R79	Overlap Arg1:T83 Arg2:T23	
R107	Overlap Arg1:T59 Arg2:T25	
R108	Overlap Arg1:T59 Arg2:T26	
R109	Overlap Arg1:T59 Arg2:T27	
R110	Overlap Arg1:T83 Arg2:T25	
R111	Overlap Arg1:T83 Arg2:T26	
R112	Overlap Arg1:T83 Arg2:T27	
R86	Overlap Arg1:T74 Arg2:T88	
R113	Overlap Arg1:T74 Arg2:T93	
R114	Overlap Arg1:T74 Arg2:T91	
R115	Overlap Arg1:T86 Arg2:T91	
R116	Overlap Arg1:T86 Arg2:T88	
R117	Overlap Arg1:T86 Arg2:T93	
R118	Overlap Arg1:T74 Arg2:T29	
R119	Overlap Arg1:T86 Arg2:T29	
#82	AnnotatorNotes T91	C5447377; SARS Coronavirus 2 Negative; Laboratory or Test Result
A18	Experiencer T53 Patient
A19	Experiencer T60 Patient
A20	Experiencer T61 Patient
A21	Experiencer T65 Patient
A22	Experiencer T71 Patient
